Savara (SVRA) Shares Outstanding (Weighted Average) (2010 - 2026)
Savara (SVRA) reported Shares Outstanding (Weighted Average) of $253.3 million for Q1 2026, up 17.18% year-over-year from $216.1 million in Q1 2025, and up 13.89% on a QoQ basis from $222.4 million in Q4 2025.
Savara (SVRA) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $253.3 million in Q1 2026.
- Quarterly Shares Outstanding (Weighted Average) rose 17.18% year-over-year to $253.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $253.3 million (up 17.18% YoY) and the FY2025 annual result came in at $222.4 million, up 12.21% from the prior year.
- Shares Outstanding (Weighted Average) climbed to $253.3 million in Q1 2026 per SVRA's latest filing, from $222.4 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $253.3 million in Q1 2026 and bottomed at $152.8 million in Q1 2022.
- The 5-year median for Shares Outstanding (Weighted Average) is $182.6 million (2024), against an average of $184.4 million.
- The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) soared 98.42%; it then rose 0.0% in 2023.
- Tracing SVRA's Shares Outstanding (Weighted Average) over 5 years: stood at $152.8 million in 2022, then gained by 8.14% to $165.2 million in 2023, then grew by 19.97% to $198.2 million in 2024, then grew by 12.21% to $222.4 million in 2025, then gained by 13.89% to $253.3 million in 2026.
- Per Business Quant, the three latest SVRA Shares Outstanding (Weighted Average) figures stand at $253.3 million (Q1 2026), $222.4 million (Q4 2025), and $216.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.04 Bn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - | 253.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 253.28 Mn |
| Dec 31, 2025 | 222.39 Mn |
| Sep 30, 2025 | 216.35 Mn |
| Jun 30, 2025 | 216.29 Mn |
| Mar 31, 2025 | 216.15 Mn |
| Dec 31, 2024 | 198.19 Mn |
| Sep 30, 2024 | 211.85 Mn |
| Jun 30, 2024 | 182.57 Mn |
| Mar 31, 2024 | 182.55 Mn |
| Dec 31, 2023 | 165.20 Mn |
| Sep 30, 2023 | 152.78 Mn |
| Jun 30, 2023 | 152.78 Mn |
| Mar 31, 2023 | 152.78 Mn |
| Dec 31, 2022 | 152.77 Mn |
| Sep 30, 2022 | 152.77 Mn |
| Jun 30, 2022 | 152.77 Mn |
| Mar 31, 2022 | 152.77 Mn |
| Dec 31, 2021 | 133.92 Mn |
| Sep 30, 2021 | 152.59 Mn |
| Jun 30, 2021 | 114.93 Mn |
| Mar 31, 2021 | 76.99 Mn |
| Dec 31, 2020 | 59.31 Mn |
| Sep 30, 2020 | 60.29 Mn |
| Jun 30, 2020 | 58.86 Mn |
| Mar 31, 2020 | 57.36 Mn |
| Dec 31, 2019 | 40.03 Mn |
| Sep 30, 2019 | 38.75 Mn |
| Jun 30, 2019 | 38.44 Mn |
| Mar 31, 2019 | 36.02 Mn |
| Dec 31, 2018 | 33.30 Mn |
| Sep 30, 2018 | 34.48 Mn |
| Jun 30, 2018 | 31.43 Mn |
| Mar 31, 2018 | 31.32 Mn |
| Dec 31, 2017 | 17.52 Mn |
| Sep 30, 2017 | 24.21 Mn |
| Jun 30, 2017 | 13.81 Mn |
| Mar 31, 2017 | 3.03 Mn |
| Dec 31, 2016 | 1.96 Mn |
| Sep 30, 2016 | 1.60 Mn |
| Jun 30, 2016 | 1.04 Mn |
| Mar 31, 2016 | 2.54 Mn |
| Dec 31, 2015 | 968,810.00 |
| Sep 30, 2015 | 163.61 Mn |
| Jun 30, 2015 | 162.13 Mn |
| Mar 31, 2015 | 159.46 Mn |
| Dec 31, 2014 | 122.41 Mn |
| Sep 30, 2014 | 123.29 Mn |
| Jun 30, 2014 | 115.59 Mn |
| Mar 31, 2014 | 105.05 Mn |
| Dec 31, 2013 | 102.71 Mn |
| Sep 30, 2013 | 102.71 Mn |
| Jun 30, 2013 | 53.75 Mn |
| Mar 31, 2013 | 46.27 Mn |
| Dec 31, 2012 | 47.64 Mn |
| Sep 30, 2012 | 47.72 Mn |
| Jun 30, 2012 | 47.72 Mn |
| Mar 31, 2012 | 47.72 Mn |
| Dec 31, 2011 | 37.09 Mn |
| Sep 30, 2011 | 26.47 Mn |
| Jun 30, 2011 | 26.25 Mn |
| Mar 31, 2011 | 22.76 Mn |
| Dec 31, 2010 | 13.18 Mn |
| Sep 30, 2010 | 14.70 Mn |
| Jun 30, 2010 | 11.52 Mn |